Reactosome
San Francisco · Founded 2023
About Reactosome
Reactosome creates a synthetic nucleus for safer, longer-lasting gene expression in gene therapy, avoiding DNA-based risks.
Company Facts
- Founded: 2023
- Legal name: Reactosome Inc
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Pre-Seed (Feb 2024)
- Website: reactosome.com
- Phone: [email protected]
Social Profiles
Canonical: https://fsome.com/organization/reactosome-8454542 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.